ACHILLION PHARMACEUTICALS INC Increase (Decrease) in Deferred Revenue
ACHILLION PHARMACEUTICALS INC reported Increase (Decrease) in Deferred Revenue of $31.59 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2016-11-03
- ACHILLION PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2012-12-31 was $0.00.
- ACHILLION PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2012-09-30 was $0.00.
- ACHILLION PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2012-06-30 was $0.00.
- ACHILLION PHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2012-03-31 was -$2.49M.
- ACHILLION PHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2012 was -$2.49M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2015-09-30 | $31.59M 10-Q · filed 2016-11-03 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $0.00 derived: sum of 2 quarters · filed 2015-03-05 | $0.00 derived: sum of 3 quarters · filed 2015-03-05 | -$2.49M 10-K · filed 2015-03-05 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | -$2.49M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$2.49M 10-Q · filed 2013-08-07 | ||
| 2012-03-31 | -$2.49M 10-Q · filed 2013-05-07 |